IFFCY 250 ORAL SUSPENSION is used to temporarily relieve fever and mild to moderate pain such as muscle ache, headache, toothache, arthritis, and backache. This medicine should be used with caution in patients with liver diseases due to the increased risk of severe adverse effects.
List of substitutes for IFFCY 250 ORAL SUSPENSION
P 250 SuspensionApex Laboratories Pvt LtdSumo L DS SuspensionAlkem Laboratories LtdNicetamol 250mg/5mlDr Reddy’s Laboratories LtdFebrex 250mg/5ml SuspensionIndoco Remedies Ltd
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. IFFCY is to be taken with food.
IFFCY is an analgesic (pain reliever) and anti-pyretic (fever reducer). It works by blocking the release of certain chemical messengers that cause pain and fever.
IFFCY 250 ORAL SUSPENSION takes around 30-45 min to start working and show its effects.
Usually, IFFCY 250 ORAL SUSPENSION stay for 5-6 hours in the body. However, this duration can vary from person to person.
No, IFFCY 250 ORAL SUSPENSION does not cause any withdrawal symptoms even if you suddenly stop taking this medicine
In adults, the total dose of IFFCY 250 ORAL SUSPENSION should not exceed 4g per day. In children, the maximum dose should not exceed 60mg/kg in a day.
Interaction with alcohol is unknown. Please consult your doctor.
IFFCY 250 ORAL SUSPENSION is probably safe to use during pregnancy. Animal studies have shown low or no adverse effect on the fetus, however, there are limited human studies. Please consult your doctor.
IFFCY 250 ORAL SUSPENSION is safe to use during lactation. Human studies have shown that either the drug does not pass into the breastmilk in significant amount or is not expected to cause toxicity to the baby. Avoid prolonged use of IFFCY 250 ORAL SUSPENSION , since it may have possible effects such as rash and diarrhea.
Not relevant, as IFFCY 250 ORAL SUSPENSION is intended for use in hospitalized patients.
There is limited information available on the use of IFFCY 250 ORAL SUSPENSION in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of IFFCY 250 ORAL SUSPENSION in patients with liver disease. Please consult your doctor.